Effects of the κ-opioid receptor agonist U-50,488 on morphine-induced place preference conditioning in the developing rat

European Journal of Pharmacology

Volumn 317, Issue 1, 1996, Pages 1-8

  Bolanos, Carlos A ^a,b   Garmsen, Gabrielle M ^a   Clair, Mark A ^a   McDougall, Sanders A ^a  

^a CALIFORNIA STATE UNIVERSITY   (United States)

^b NORTHEASTERN UNIVERSITY   (United States)

Author keywords

Morphine; Ontogeny; Rat; Reward; U 50,488

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; COCAINE; MORPHINE; OPIATE AGONIST;

ANIMAL EXPERIMENT; ARTICLE; BRAIN REGION; CONDITIONING; CONTROLLED STUDY; DRUG EFFECT; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; NONHUMAN; ONTOGENY; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANALGESICS; ANIMALS; CONDITIONING, OPERANT; FEMALE; MALE; MORPHINE; MOTOR ACTIVITY; NARCOTICS; PYRROLIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, KAPPA;

EID: 0030581747     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(96)00698-X     Document Type: Article

References (52)

1. Arnt, J., 1987, Behavioral studies of dopamine receptors: Evidence for regional selectivity and receptor multiplicity, in: Receptor Biochemistry and Methodology, Dopamine Receptors, eds. I. Creese and C.M. Fraser, Vol. 8 (Alan R. Liss, New York, NY) p. 199.
2. Bals-Kubik, R., A. Ableitner, A. Herz and T.S. Shippenberg, 1993, Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats, J. Pharmacol. Exp. Ther. 264, 489.
3. Bardo, M.T., J.L. Neisewander and J.S. Miller, 1986, Repeated testing attenuates conditioned place preference with cocaine, Psychopharmacology 89, 239.
4. Bardo, M.T., J.K. Rowlett and M.J. Harris, 1995, Conditioned place preference using opiate and stimulant drugs: A meta-analysis. Neurosci. Biobehav. Rev. 19, 39.
5. Barr, G.A. and G. Rossi, 1992, Conditioned place preference produced by local injection of morphine into the ventral tegmental area of 3-day old rats. Dev. Brain Res. 66, 133.
6. Barr, G.A., S. Wang and S. Garden, 1994, Aversive properties of the k opioid agonist U50,488 in the week old rat pup. Psychopharmacology 113, 422.
7. Boyle, A.E., K. Gill, B.R. Smith and Z. Amit, 1991, Differential effects of an early housing manipulation on cocaine-induced activity and self-administration in laboratory rats, Pharmacol. Biochem. Behav. 39, 269.
8. Cameron, D.L. and A.D. Crocker, 1989, Localization of striatal dopamine receptor function by central injection of an irreversible receptor antagonist, Neuroscience 32, 769.
9. Garden, S.E., G.A. Barr and M.A. Hofer, 1991, Differential effects of specific opioid receptor agonists on rat pup isolation calls, Dev. Brain Res. 62, 17.
10. Garden, S.E., L. Davachi and M.A. Hofer, 1994, U50,488 increases ultrasonic vocalizations in 3-, 10-, and 18-day-old rat pups in isolation and the home cage, Dev. Psychobiol. 27, 65.
11. Caza, P. and L.P. Spear, 1980, Ontogenesis of morphine-induced behavior in the rat, Pharmacol. Biochem. Behav. 13, 45.
12. Crawford, C.A., S. Nguyen, S.E. Hall and S.P. Berger, 1994, Microdialysis and behavioral evidence of the functional antagonism of cocaine by the kappa agonist U50488, NIDA Res. Monogr. 141, 107.
13. Crawford, C.A., S.A. McDougall, C.A. Bolanos, S. Hall and S.P. Berger, 1995. The effects of the kappa agonist U-50,488 on cocaine-induced conditioned and unconditioned behaviors and Fos immunoreactivity, Psychopharmacology 107, 392.
14. Di Chiara, G. and A. Imperato, 1988, Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats, J. Pharmacol. Exp. Ther. 244, 1067.
15. Di Chiara, G. and A.R. North, 1992, Neurobiology of opiate abuse, Trends Pharmacol. Sci. 13, 177.
16. Ettenberg, A., H.O. Pettit, F.E. Bloom and G.F. Koob, 1982, Heroin and cocaine self-administration in rats: Mediation by separate neuronal systems, Psychopharmacology 78, 204.
17. Funada, M., T. Suzuki, M. Narita, M. Misawa and H. Nagase, 1993. Blockade of morphine reward through the activation of κ-opioid receptors in mice, Neuropharmacology 32, 1315.
18. Gallistel, C.R. and D. Karras, 1984, Pimozide and amphetamine have opposing effects on the reward summation function, Pharmacol. Biochem. Behav. 20, 73.
19. Heimer, L., D.S. Zahm, L. Churchill, P.W. Kalivas and C. Wohltman, 1991, Specificity in the projection patterns of accumbal core and shell in the rat, Neuroscience 41, 89.
20. Hiroi, N. and N.M. White, 1991, The amphetamine conditioned place preference: Differential involvement of dopamine receptor subtypes and two dopaminergic terminal areas, Brain Res. 552, 141.
21. Jackson, H.C. and I. Kitchen, 1989, Behavioral effects of selective μ-, κ-, and δ-opioid agonists in neonatal rats, Psychopharmacology 97, 404.
22. Kehoe, P. and E.M. Blass, 1986, Behaviorally functional opioid systems in infant rats. Evidence for olfactory and gustatory classical conditioning, Behav. Neurosci. 100, 359.
23. Kehoe, P. and C.B. Boylan, 1994, Behavioral effects of kappa-opioid-receptor stimulation in neonatal rats, Behav, Neurosci. 108, 418.
24. Koob, G.F., 1992, Drugs of abuse: Anatomy, pharmacology and function of reward pathways, Trends Pharmacol. Sci. 13, 177.
25. Lanier, L.P. and R.L. Isaacson, 1977, Early developmental changes in the locomotor response to amphetamine and their relation to hippocampal function. Brain Res. 126, 567.
26. Laviola, G., G. Dell'Omo, E. Alleva and G. Bignami, 1992, Ontogeny of cocaine hyperactivity and conditioned place preference in mice, Psychopharmacology 107, 221.
27. Maisonneuve, I.M., S. Archer and S.D. Glick, 1994, U50,488, a k opioid receptor agonist, attenuates cocaine-induced increases in extracellular dopamine in the nucleus accumbens of rats, Neurosci. Lett. 181, 57.
28. Mansour, A., H. Khachaturian, M.E. Lewis, H. Akil and H.J. Watson, 1987, Autoradiographic differentiation of mu, delta, and kappa opioid receptors in the rat forebrain and midbrain, J. Neurosci. 7, 2445.
29. McDougall, S.A., A.J. Nonneman and C.A. Crawford, 1991, Effects of SCH 23390 and sulpiride on the reinforced responding of the young rat, Behav. Neurosci. 105, 744.
30. McDougall, S.A., C.A. Crawford and A.J. Nonneman, 1992, Reinforced responding of the 11-day-old rat pup: Synergistic interaction of D-1 and D-2 dopamine receptors, Pharmacol. Biochem. Behav. 42, 163.
31. Mucha, R.F. and A. Herz, 1985, Motivational properties of kappa and mu opioid receptor agonists studied with place and taste preference conditioning, Psychopharmacology 86, 274.
32. Pettit, H.O. and J.B. Justice, 1991, Effect of dose on cocaine self-administration behavior and dopamine levels in the nucleus accumbens, Brain Res. 539, 94.
33. 2 receptor antagonists on cocaine-induced place preference conditioning in preweanling rats, Eur. J. Pharmacol. 107, 125.
34. Randall, C.K., P.J. Kraemer, J.M. Dose, T.J. Carbary and M.T. Bardo, 1992, The biphasic effect of morphine on odor conditioning in neonatal rats, Dev. Psychobiol. 25, 355.
35. Schnur, P. and J.M. Walker, 1990, Effects of U50,488H on locomotor activity in the hamster, Pharmacol. Biochem. Behav. 36, 813.
36. Shippenberg, T.S., R. Bals-Kubik and A. Herz, 1987, Motivational properties of opioids: Evidence that an activation of delta-receptors mediates the reinforcement process, Brain Res. 436, 234.
37. 1-dopamine receptors in the motivational properties of μ-and κ-opioid agonists, Brain Res. 436, 169.
38. Shippenberg, T.S. and A. Herz, 1991, Influence of chronic lithium treatment upon the motivational effects of opioids: alteration in the effects of mu-but not kappa-opioid receptor ligands, J. Pharmacol. Exp. Ther. 256, 1101.
39. Smith, C.A. and E.W. Holman, 1987, Rewarding and aversive effects of stimulant drugs in infant rats, Pharmacol. Biochem. Behav. 26, 211.
40. Smotherman, W.P., C.A. Moody, L.P. Spear and S.R. Robinson, 1993, Fetal behavior and the endogenous opioid system: D1 dopamine receptor interactions with the kappa opioid system, Physiol. Behav. 53, 191.
41. Spanagel, R., A. Herz and T.S. Shippenberg, 1990, The effects of opioid peptides on dopamine release in the nucleus accumbens: An in vivo microdialysis study, J. Neurochem. 55, 1734.
42. Spanagel, R., A. Herz and T.S. Shippenberg, 1992, Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway, Proc. Nat. Acad. Sci. USA 89, 2046.
43. Spear, L.P., 1979, The use of psychopharmacological procedures to analyze the ontogeny of learning and retention: Issues and concerns, in: Ontogeny of Learning and Memory, eds. N.E. Spear and B.A. Campbell (Lawrence Erlbaum Associates, Hillsdale, NJ, USA) p. 135.
44. Spear, L.P. and S.C. Brake, 1983, Periadolescence: Age-dependent behavior and psychopharmacological responsivity in rats, Dev. Psychobiol. 16, 83.
45. Spear, L.P. and J. Brick, 1979, Cocaine-induced behavior in the developing rat, Behav. Neur. Biol. 26, 401.
46. Spear, L.P., G.P. Horowitz and J. Lipovsky, 1982, Altered behavioral responsiveness to morphine during peri-adolescent period in rats, Behav. Brain Res. 4, 279.
47. Stinus, L., D. Nadaud, J.-M. Deminiere, J. Jauregui, T.T. Hand and M. Le Moal, 1989, Chronic flupentixol treatment potentiates the reinforcing properties of systemic heroin administration, Biol. Psychiatry 26, 363.
48. Suzuki, T., Y. Shiozaki, Y. Masukawa, M. Misawa and H. Nagase, 1992, The role of mu-and kappa-opioid receptors in cocaine-induced conditioned place preference, Jpn. J. Pharmacol. 58, 435.
49. Ukai, M. and T. Kameyama, 1985, Multi-dimensional analyses of behavior in mice treated with U-50, 488H, a purported kappa (non-mu) opioid agonist, Brain Res. 337, 352.
50. Vezina, P. and J. Stewart, 1987. Morphine conditioned place preference and locomotion: The effect of confinement during training, Psychopharmacology 93, 257.
51. VonVoigtlander, P.F., R.A. Lahti and J.H. Ludens, 1983, U-50, 488: A selective and structurally novel non-mu (kappa) opioid agonist, J. Pharmacol. Exp. Ther. 224, 7.
52. Wise. R.A. and M.A. Bozarth, 1987, A psychomotor stimulant theory of addiction, Psych. Rev. 94, 469.